What are the topical treatment options for solar lentigines (lentigines solares, also known as age spots or liver spots)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Topical retinoids, such as adapalene 0.3%, are the most effective treatment for solar lentigines, as they have been shown to improve lentigines and reduce wrinkles, with a strength of recommendation B and level of evidence 1+ 1. When considering treatment options for solar lentigines, it's essential to prioritize treatments that have been proven to be effective in improving lentigines and reducing wrinkles.

  • Topical retinoids, including adapalene 0.3%, tretinoin 0.1%, and topical isotretinoin 0.1%, have been demonstrated to have a modest benefit in improving lentigines and reducing wrinkles 1.
  • Adapalene 0.3% has been shown to be significantly more efficacious than adapalene 0.1% in achieving AK count reduction after 9 months 1.
  • While other treatments, such as hydroquinone, chemical exfoliants, and vitamin C serums, may also be effective in lightening pigmentation, the evidence supporting their use is not as strong as that for topical retinoids 1.
  • Consistent sun protection with broad-spectrum SPF 30+ is essential to prevent recurrence of solar lentigines, as UV exposure triggers melanin production.
  • Results from topical retinoid treatment typically take several months to become noticeable, and treatments should be discontinued if significant irritation occurs.
  • Some patients may require combination therapy or professional procedures like chemical peels or laser treatments for stubborn lentigines.

From the Research

Topical Treatment Options for Solar Lentigines

  • The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin has been shown to be effective in improving the appearance of solar lentigines and related hyperpigmented lesions 2.
  • Topical retinoids, such as tretinoin, have been used as depigmenting agents, but may have a lower response rate compared to combination-based treatments 3.
  • Stabilized cysteamine has been found to be a highly effective topical treatment for solar lentigines, providing a 40% reduction in colorimetric values and a 40% reduction in visual analog scale (VAS) scores 4.

Efficacy and Safety of Topical Treatments

  • The 4HA/tretinoin combination was clinically superior to each of its active components and to the vehicle in the treatment of solar lentigines, with most skin-related adverse events being mild 2.
  • Combination-based treatments, including 2% mequinol/0.01% tretinoin, have been shown to be well-tolerated and effective in reducing lesion darkness 5.
  • Stabilized cysteamine was found to be safe and effective, with significant improvement in solar lentigines observed after 12 weeks of application 4.

Comparison of Topical Treatments

  • A systematic review found that combination-based treatments and laser-based treatments were the most efficacious treatment modalities for solar lentigines, with topical retinoids and cryotherapy having lower response rates 3.
  • Chemical peels and cryotherapy can also be effective in treating solar lentigines, either alone or in combination with topical therapy 5.
  • The choice of topical treatment for solar lentigines should be based on individual patient needs and preferences, as well as the potential risks and benefits of each treatment option 2, 3, 5, 6, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of Lentigines: A Systematic Review.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2023

Research

Combination therapy for solar lentigines.

Journal of drugs in dermatology : JDD, 2004

Research

A promising new treatment for solar lentigines.

Journal of drugs in dermatology : JDD, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.